| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |